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ARTICLE
Collagen-producing lung cell atlas identifies
multiple subsets with distinct localization and
relevance to fibrosis
Tatsuya Tsukui 1, Kai-Hui Sun1, Joseph B. Wetter2, John R. Wilson-Kanamori3, Lisa A. Hazelwood2,
Neil C. Henderson 3, Taylor S. Adams4, Jonas C. Schupp 4, Sergio D. Poli5, Ivan O. Rosas5,
Naftali Kaminski 4, Michael A. Matthay6, Paul J. Wolters7 & Dean Sheppard 1✉
Collagen-producing cells maintain the complex architecture of the lung and drive pathologic
scarring in pulmonary fibrosis. Here we perform single-cell RNA-sequencing to identify all
collagen-producing cells in normal and fibrotic lungs. We characterize multiple collagen-
producing subpopulations with distinct anatomical localizations in different compartments of
murine lungs. One subpopulation, characterized by expression of Cthrc1 (collagen triple helix
repeat containing 1), emerges in fibrotic lungs and expresses the highest levels of collagens.
Single-cell RNA-sequencing of human lungs, including those from idiopathic pulmonary
fibrosis and scleroderma patients, demonstrate similar heterogeneity and CTHRC1-expressing
fibroblasts present uniquely in fibrotic lungs. Immunostaining and in situ hybridization show
that these cells are concentrated within fibroblastic foci. We purify collagen-producing
subpopulations and find disease-relevant phenotypes of Cthrc1-expressing fibroblasts in
in vitro and adoptive transfer experiments. Our atlas of collagen-producing cells provides a
roadmap for studying the roles of these unique populations in homeostasis and pathologic
fibrosis.
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The lung is a complex organ with marked regional differ-ences in structure and function. Important sub-structuresin the lung include the conducting airways, responsible
for filtering and delivering inhaled and exhaled air, the
bronchovascular bundles, conduits for air, blood, and lympha-
tics, and the alveolar region, responsible for gas exchange1.
Collagens play central roles in maintaining the organization and
structural integrity of these distinct anatomic features2. Pertur-
bation of collagen homeostasis is an important contributor to
common lung diseases, including pulmonary fibrosis. However,
the cells responsible for normal collagen production in each of
these regions and for excess accumulation of collagen in fibrotic
lung diseases have not been well characterized. It has been
widely assumed that there is a single cell type, often called a
myofibroblast and characterized by expression of the contractile
protein alpha-smooth muscle actin (α-SMA), that is the major
collagen-producing cell in the lung. However, previous work by
ourselves and others suggest that α-SMA is an inconsistent
marker of collagen-producing cells in in normal murine lungs
and in murine models of pulmonary fibrosis3,4. To enhance
progress in understanding the cellular and molecular mechan-
isms underlying normal collagen homeostasis and fibrotic lung
diseases, a better understanding of the cells responsible for
collagen production is urgently needed.
The development of single-cell RNA-sequencing (scRNA-seq)
allows us to evaluate the heterogeneity of tissue cell types with
markedly improved precision. Several recently published studies
have used this approach to characterize some of the mesench-
ymal populations in the lung. Zepp et al. identified mesenchymal
alveolar niche cells and myogenic progenitor cells by using
Axin2-CreER/Pdgfra-GFP/Wnt2-CreER reporter mice5. Xie
et al. collected mesenchymal populations more broadly by
sorting CD31, CD45, and Epcam-negative cells, and described
6–7 mesenchymal populations in normal and fibrotic murine
lungs6. Another recent study performed scRNA-seq on all cells
obtained with a single digestion protocol from fibrotic human
lungs, but the overwhelming majority of cells obtained and
analyzed were leukocytes and epithelial cells, with very few cells
that were characterized as fibroblasts7. Overall, no studies to
date have specifically focused on the cells responsible for pro-
duction of collagen and other extracellular matrix (ECM) pro-
teins and the anatomic location of these cell types in normal and
fibrotic lungs.
Here, we perform scRNA-seq of cells obtained with a protocol
designed to capture all of the collagen-producing cells from
normal and fibrotic mouse and human lungs. We use gene
expression signatures to classify fibroblast subpopulations based
on their anatomical localizations, and developed fluorescence-
activated cell sorting (FACS) strategies to purify those popula-
tions. Through this approach, we identify molecularly distinct
populations of fibroblasts that populate distinct anatomic loca-
tions, in the walls of conducting airways (peribronchial), sur-
rounding bronchovascular bundles (adventitial) and embedded
within the alveolar regions of the lung (alveolar). We also
identify a unique population of Cthrc1 (collagen triple helix
repeat containing 1)+ fibroblasts, which are mostly found in
fibrotic lungs in both mice and humans and expresses the
highest levels of type 1 collagen and other ECM genes. Purified
Cthrc1+ fibroblasts are more migratory than other subsets of
collagen-producing cells and demonstrate an enhanced capacity
to colonize the lungs of bleomycin-treated mice. These findings
identify the distinct gene and cell surface protein expression
patterns that characterize fibroblast subsets with distinct ana-
tomic localizations. The Cthrc1+ subset we describe is likely to
play an important role in the development of pulmonary fibrosis
in mice and humans.
Results
scRNA-seq of murine lung cells in normal and fibrotic lungs.
We used Col1a1-EGFP (Col-GFP) reporter mice to harvest all of
the collagen-producing cells in murine lungs8. We induced lung
fibrosis by intratracheally instilling bleomycin into two Col-GFP
mice, and prepared a single cell suspension from the lungs
14 days after the bleomycin treatment. Two untreated Col-GFP
mice were used as control. In addition to GFP+ cells, we sorted
GFP− cells to compare gene expression patterns in the cells
responsible for collagen production to pattern seen in other cell
types. We performed scRNA-seq of each sample using the 10x
Genomics platform (Fig. 1a). After quality filtering, we obtained
25953 cell profiles from all the GFP+ and GFP− samples. We
performed dimensionality reduction with canonical correlation
analysis (CCA) subspace alignment and performed unsupervised
clustering (Fig. 1b)9. Analysis of representative markers identified
clusters of endothelial, epithelial, and mesothelial cells as well as
hematopoietic cells including macrophages, monocytes, neu-
trophils, dendritic cells, natural killer cells, and lymphocytes
(Fig. 1c, Supplementary Fig. 1a). To characterize the hetero-
geneity of collagen-producing cells in higher resolution, we
focused on the cells from GFP+ samples and removed all clusters
with lineage markers, which did not consistently express Col1a1
except a small cluster of mesothelial cells (Fig. 1c). Re-clustering
of Col1a1+ cells revealed 12 clusters from 12,855 cells (Fig. 1d).
All the clusters included cells from both bleomycin-treated and
untreated lungs except clusters 8 and 11, which were mostly from
bleomycin-treated lungs (Fig. 1e, Supplementary Fig. 1b). The
clusters were categorized into two superclusters: one composed of
clusters 0, 1, 2, 4, 6, 8, 10 with higher Col1a1 expression, and the
other composed of clusters 3, 5, 7, 9 with higher Acta2 expression
(Fig. 1f). Cluster 11 is proliferating cells characterized by the
expression of Mki67 and Cdc20 (Supplementary Fig. 1c). Clusters
5 and 7 expressed smooth muscle cell markers such as Acta2 and
Myh11 (Fig. 1f, g). Cluster 9 expressed pericyte markers such as
Mcam, Cspg4 and the highest level of Pdgfrb (Fig. 1g).
Identification of fibroblast subsets in normal lungs. To further
characterize these populations, we performed differentially
expressed gene analysis and identified expression markers of
clusters of interest (Fig. 2a). Clusters 0, 1, 2, 10 shared common
markers including Npnt and Ces1d (Fig. 2a). Slc7a10 is specifically
expressed in cluster 0 (Fig. 2a). Clusters 4 and 6 shared some
markers such as Pi16 and Dcn (Fig. 2a). Cluster 4 uniquely
expressed cytokines such as Il33 and Ccl11, while cluster 6
uniquely expressed Adh7 (Fig. 2a). Cluster 3 highly expressed
Hhip, Aspn and Fgf18 (Fig. 2a).
To examine the localization of these clusters in vivo, we used
proximity ligation in situ hybridization (PLISH), a recently-
reported in situ hybridization technology with high sensitivity
and specificity10. The PLISH signal is observed as bright dots,
which represent the cellular locations of target mRNA. In normal
lungs, Col-GFP+ cells were mainly detected at alveolar walls and
adventitial cuffs surrounding large airways and arteries in
bronchovascular bundles (Supplementary Fig. 2a). We found
that Col-GFP+ cells in alveoli expressed both Npnt and Ces1d,
markers for clusters 0, 1, 2, 10 (Fig. 2b). We also detected Ces1d
signals in airway epithelial cells, which is consistent with our
whole lung scRNA-seq data (Supplementary Fig. 2b), but not in
Col-GFP+ cells in bronchovascular cuffs (Fig. 2b). Among these
alveolar fibroblast clusters, cluster 0 was most prominent in the
lungs of untreated mice (Fig. 1e, Supplementary Fig. 1b). In
contrast, Pi16 was expressed by Col-GFP+ cells in the cuffs
(Fig. 2c). Adh7, a marker for cluster 6, was also detected in Col-
GFP+ cells in the cuffs (Fig. 2c). Furthermore, signals for Ccl11
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were enriched in Col-GFP+ cells in the cuffs (Fig. 2d). These
findings are consistent with a recent report, which identified Il33-
expressing stromal cells in the adventitial cuffs11, but also
suggests that there is another kind of adventitial fibroblast
characterized by Adh7 expression that does not express
cytokine genes.
A previous study identified Hhip+ mesenchymal cells around
airways in the lung12. PLISH for Hhip and Aspn, markers for
cluster 3, also showed signal enrichment in subepithelial Col-GFP+
cells around bronchi (Fig. 2e). Those Hhip+ Col-GFP+ sub-
epithelial cells were distinct from airway smooth muscle cells
characterized by Actc1 expression (Supplementary Fig. 2c, d).
Three-dimensional imaging of cleared thick lung sections of
Col-GFP mice revealed that those subepithelial Col-GFP+ cells
were intercalated between airway smooth muscle cells localized
just below the airway epithelium (Fig. 3a, b, Supplementary
Movie 1). Type 4 collagen staining showed that subepithelial Col-
GFP+ cells made contacts with epithelial basement membranes
(Fig. 3c, Supplementary Movie 2). Adventitial fibroblasts closely
associated with type 4 collagen surrounding the bronchovascular
cuffs (Fig. 3c, Supplementary Movie 2). A previous report showed
that Pdgfra+ cells in alveolar walls have close association with
type 2 alveolar epithelial cells (AEC2s)13. We crossed Col-GFP
mice with Shh-Cre/Rosa26-lox-stop-lox-tdTomato mice, in
which all epithelial cells in the lung express tdTomato14, to
investigate the interaction of Col-GFP+ cells and epithelial cells in
alveoli. Consistent with the previous report, alveolar fibroblasts
were located in close proximity to AEC2s (Fig. 3d, Supplementary
Movie 3).
These results identify 4 subclusters of alveolar fibroblasts
(clusters 0, 1, 2, 10), two types of adventitial fibroblasts (clusters 4,
6), and a cluster of peribronchial fibroblasts (clusters 3) (Fig. 3e).
These fibroblast subpopulations have distinct localizations in
different compartments of the lung (Fig. 3f).
Population comparison to previous studies. Cluster 3 also
expressed Lgr5 (Supplementary Fig. 3a), suggesting that peri-
bronchial fibroblasts may correspond to the Lgr5+ mesenchymal
cells reported by Lee et al.15. Lgr6 was expressed by cluster 3 and
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Fig. 1 scRNA-seq of murine lung cells in normal and fibrotic lungs. a Schematic of scRNA-seq sample preparation. b Uniform manifold approximation and
projection (UMAP) plot of all cells colored by GFP+ and GFP− samples. c Col1a1 expression on UMAP plot of all cells. See Supplementary Fig. 1a for
identifying the lineages. NK, natural killer cell; Neut, neutrophil; Mac, macrophage; DC, dendritic cell; Mono, monocyte. d–f UMAP plots of Col1a1+ cells.
d Unsupervised clustering identifies 12 clusters. e Cells from bleomycin-treated lung are shown in red. Cells from untreated lungs are shown in blue.
f, g Gene expression levels for each gene.
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Fig. 2 Identification of alveolar, adventitial, and peribronchial fibroblasts in untreated lungs. a Violin plots showing the expression levels in each cluster
of representative marker genes. b, c Proximity ligation in situ hybridization (PLISH) images for Npnt (white) and Ces1d (magenta) (b), or for Pi16 (white)
and Adh7 (magenta) (c). Magnified images of the white squares are shown in right panels. Arrows indicate co-localization of PLISH signals in GFP+ cells.
d PLISH images for Ccl11 (white) and Adh7 (magenta). e PLISH images for Hhip (white) and Aspn (magenta). Magnified images of the white square are
shown in right panels. Arrows indicate co-localization of PLISH signals in GFP+ cells. b–e Col-GFP is shown in green. DAPI signal is shown in blue. Scale
bars, 50 μm. aw, airway; bv, blood vessel; cuff, cuff space. Images are representative of three experiments (n≥ 2).
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some of the smooth muscle cells (Supplementary Fig. 3a)15. Zepp
et al. used Axin2, Pdgfra, and Wnt2 to classify mesenchymal
populations5. Axin2 was broadly expressed in all mesenchymal
populations in our data set (Supplementary Fig. 3b). Wnt2 was
mainly expressed in clusters 0, 1, 2 (Supplementary Fig. 3b). Sfrp4
and Wif1 were reported as markers for mesenchymal alveolar
niche cells (MANC)5. Cluster 4 expressed Sfrp4, and clusters 3, 6
expressedWif1 in our data set (Supplementary Fig. 3b). Clusters 5,
7, 9, which are smooth muscle cells and pericytes, expressed the
markers of Axin2+ myofibrogenic progenitor (AMP), Notch3 and
Gucy1a3 (Supplementary Fig. 3b)5. Xie et al. reported Col13a1 and
Col14a1 expressing fibroblasts6. Clusters 0, 1, 2 expressed Col13a1,
and clusters 4, 6 expressed Col14a1 (Supplementary Fig. 3c). The
population described as “myofibroblasts” in Xie et al. has the same
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markers as cluster 3, including Hhip and Aspn (Fig. 2a). Higd1b
and Cox4i2, which are the markers of Pdgfrb hi populations in Xie
et al., were expressed in pericytes (cluster 9), although we found
pericytes from both untreated and bleomycin-treated lungs unlike
Xie et al. (Fig. 1e, Supplementary Fig. 3c)6. This apparent differ-
ence could be explained by differences in the digestion protocols
used. The specific markers for the cells described as “lipofibro-
blasts” in Xie et al. such as Ear1, Ear2, Mrc1, or Clec4n, were all
expressed in Ptprc (CD45)+ Itgax (CD11c)+ Siglecf+ alveolar
macrophages (Supplementary Fig. 1a, 3d)6. General lipofibroblast
markers such as Plin2 and Lpl were also expressed in clusters 0, 1,
2, consistent with previous reports that Pdgfra+ Tcf21+ Col13a1+
alveolar fibroblasts have some phenotypic features of lipofibro-
blasts (Supplementary Fig. 3e)13,16.
Cthrc1+ cells express pathologic ECM genes in fibrotic lungs.
Next, we analyzed specific markers for cluster 8, which was
mostly from bleomycin-treated lungs. Cluster 8 specifically
expressed Cthrc1, which was previously shown to be increased in
bulk RNA sequencing from the lungs of patients with idiopathic
pulmonary fibrosis (IPF) (Fig. 4a)17. Other markers for cluster 8
include ECM-related genes such as Postn, Spp1, Fn1, and Tnc
(Fig. 4a). Col1a1 and Col3a1 expression were also the highest in
cluster 8 (Fig. 4a). Feature plots of Col1a1 and Cthrc1 showed the
correlation of the two genes in bleomycin-treated lungs (Fig. 4b).
Cthrc1 was specific for the population with the highest collagen
expression and not significantly detected in other lung cells, while
the myofibroblast marker, Acta2 was predominantly expressed by
low collagen-expressing cells (Supplementary Fig. 4a). PLISH for
Cthrc1 and Col1a1 in bleomycin-treated lung sections showed
that Cthrc1 was expressed at the periphery of clusters of Col1a1+
cells in the alveolar region (Fig. 4c). To computationally inves-
tigate the potential progenitors of Cthrc1+ fibroblasts, we per-
formed RNA velocity analysis, in which the direction of cellular
differentiation is predicted based on the reads from both spliced
and unspliced RNA18. Vectors pointing into cluster 8 mostly
came from cluster 2, which expresses multiple markers of alveolar
fibroblasts (Fig. 4d). This analysis is consistent with the alveolar
localization of Cthrc1+ fibroblasts. To further characterize the
relevance of alveolar fibroblasts and cluster 8, we zoomed in on
clusters 0, 1, 2, 8 (Fig. 4e), and performed pseudotime trajectory
analysis19. The resulting trajectory proposed a differentiation
from cells in cluster 0 into clusters 1 and 2, with cells in cluster 8
forming a terminal state at the end (Fig. 4f). These results suggest
that Cthrc1+ fibroblasts are activated to produce pathologic ECM
in fibrotic lesions and may principally differentiate from alveolar
fibroblasts.
Interestingly, we found that the expression of alveolar
fibroblast markers, such as Pdgfra, Npnt, Ces1d, and Tcf21
gradually decreased along the pseudotime towards cluster 8
(Fig. 4g, h, Supplementary Fig. 4b), while ECM genes such as
Col1a1, Col3a1, and Col5a1 gradually increased along the
pseudotime (Fig. 4g, h, Supplementary Fig. 4b). These results
may indicate the differentiation of alveolar fibroblasts into
functionally distinct ECM-producing cells.
Peyser et al. suggested that activated fibroblasts were not
uniquely defined from scRNA-seq of bleomycin-treated mouse
lungs20. To clarify the discrepancy to our data, we analyzed their
scRNA-seq data (GSE129605). After focusing on Col1a1+ cells, we
found that a fraction of Col1a1+ cells, that expressed the highest
levels of collagen and were mainly from bleomycin-treated lungs,
grouped together and expressed cluster 8 markers such as Cthrc1,
Tnc, Spp1, and Fst, consistent with our findings (Supplementary
Fig. 4c). These pathologic fibroblasts were not bioinformatically
identified as a distinct cluster possibly because there were
relatively small number of Col1a1+ cells (~2000 cells)21. It is also
possible that the dissociation conditions used in Peyser et al. did
not capture all of these cells.
scRNA-seq of normal and fibrotic lungs of human. Next, we
performed scRNA-seq of human lung cells to explore the
heterogeneity of collagen-producing cells in normal and
fibrotic lungs. We collected samples from explanted lungs of
three IPF patients and two scleroderma patients, which allowed
us to compare pathologic collagen-producing populations in
two fibrotic diseases with different etiology. Three normal lung
samples were collected from rejected lung transplant donors.
We sorted lineage (CD31, CD45, CD235a, EPCAM)− cells to
enrich mesenchymal cells. We also collected CD235a (ery-
throcyte marker)− cells as all lung cells. All the cell profiles
were aggregated with mutual nearest neighbors (MNN) batch
correction, which is effective for correcting diverse batch-to-
batch differences (Fig. 5a)22. We obtained 83316 cells after
quality filtering. By analyzing representative markers, we
identified T cells, B cells, dendritic cells, epithelial cells,
endothelial cells, macrophages, and COL1A1+ mesenchymal
cells (Fig. 5b, Supplementary Fig. 5a). To characterize the
heterogeneity of collagen-producing cell populations, we
focused on lineage− samples and re-clustered COL1A1+ cells
(Fig. 5c). Unsupervised clustering identified 7 clusters from
48,587 cells (Fig. 5d). Cell number of each cluster from each
disease is shown in Supplementary Fig. 5b. Clusters 1, 3, 4
expressed PDGFRA, and clusters 0, 2, 6 expressed PDGFRB
(Fig. 5e). Cluster 0 expressed pericyte markers including RGS5
and MCAM, and clusters 2, 6 expressed the highest levels of
smooth muscle markers including MYH11 and MYL9 (Fig. 5e).
We observed increased number of pericytes (cluster 0) both in
IPF and scleroderma lungs (Supplementary Fig. 5b). Cluster 1,
which was enriched with cells from normal lungs, expressed
alveolar fibroblast markers such as NPNT and CES1 (Fig. 5e,
Supplementary Fig. 5b). Cluster 4 expressed the markers of
adventitial fibroblasts such as PI16 and DCN (Fig. 5e). Cluster
5 markers include FGF18 and WIF1, which were also expressed
in peribronchial fibroblasts in mice (Fig. 5e). Cluster 3 showed
the highest COL1A1 expression and was enriched with cells
from fibrosis patients (Fig. 5c, f, Supplementary Fig. 5b). As
seen in mice, CTHRC1 expression correlated with COL1A1
expression and was largely restricted to cells from fibrotic
lungs, and ACTA2 expression was poorly correlated with
COL1A1 (Fig. 5f). These findings were consistent across all the
samples we obtained (Supplementary Fig. 5c). As we found in
mice, CTHRC1+ cells also expressed other ECM genes such as
TNC, POSTN, and COL3A1 (Fig. 5g).
To examine the consistency of our findings in larger data sets,
we investigated scRNA-seq data from 29 normal and 32 IPF
lungs23. After focusing on COL1A1+ cells, we found similar
heterogeneous populations including RGS5+ CSPG4+ pericytes,
MYH11+ MYL9+ smooth muscle cells, NPNT+ CES1+ alveolar
fibroblasts, and PI16+ DCN+ adventitial fibroblasts (Supplemen-
tary Fig. 6a, b). A fraction of cells, which were mainly from IPF
lungs, highly expressed CTHRC1 and other ECM-related genes
such as COL1A1, COL3A1, TNC, and POSTN (Supplementary
Fig. 6c). Emergence of CTHRC1+ fibroblasts in lungs of
scleroderma patients was also reported in a recent scRNA-seq
study24. Moreover, we analyzed scRNA-seq data (GSE128033)
from Morse et al.25, in which the authors collected samples from
3 normal and 3 IPF lungs. We found that, consistent with our
findings, a fraction of COL1A1+ cells expressed CTHRC1 and
other ECM-related genes but not the highest level of ACTA2
(Supplementary Fig. 6d).
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To localize pathologic fibroblasts in fibrotic lungs, we
performed RNAScope in situ hybridization (ISH) and antibody
staining for CTHRC1 in IPF lung sections (Fig. 6a). The highest
CTHRC1 RNA and protein expression was observed within
fibroblastic foci, which are known as active sites of collagen
production and leading edges of fibrogenesis (Fig. 6a)26,27. These
results support the idea that CTHRC1+ fibroblasts could
contribute to pathologic fibrogenesis in IPF. Previous reports
showed that fibroblastic foci in IPF are α-SMA-positive26. To
investigate the relation between CTHRC1+ pathologic fibroblasts
and α-SMA+ cells, we stained sequential sections of IPF lungs for
these markers (Fig. 6b). Although fibroblastic foci populated with
CTHRC1+ pathologic fibroblasts were also positive for α-SMA,
α-SMA+ cells were also evident outside fibroblastic foci (Fig. 6b).
Taken together with our scRNA-seq data showing the higher
ACTA2 expression in smooth muscle cells and pericytes, these
data suggest that α-SMA is not a specific marker of pathologic
fibroblasts producing the highest levels of ECM.
FACS purification of fibroblast subsets. One of the challenges in
fibrosis research is a lack of methodology to purify mesenchymal
subpopulations. To establish the methodology in mouse, we
sought surface markers specific for each of the collagen-
producing subpopulations. Pdgfra was widely expressed by
alveolar and adventitial fibroblasts, although Cthrc1+ cluster 8
expressed relatively low levels of Pdgfra (Fig. 1g). We found that
adventitial but not alveolar fibroblasts expressed Ly6a (Fig. 7a).
Peribronchial fibroblasts were negative for Pdgfra but highly
expressed Cd9 (Fig. 7a). These results suggest that alveolar,
adventitial, and peribronchial fibroblasts can be distinguished by
the expressions of Pdgfra, Ly6a, and Cd9, while smooth muscle
cells and pericytes can be distinguished by Mcam (Fig. 7b). To
confirm this, we stained lung cells from untreated Col-GFP mice
for these markers and performed sorting via FACS. After gating
dump (CD31, CD45, EpCAM, Ter119)− and GFP+ cells, we
purified Mcam+ cells, Mcam− Sca1 (Ly6a)+ cells as adventitial
fibroblasts, Mcam− Sca1− Pdgfra+ cells as alveolar fibroblasts,
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and Mcam− Sca1− Pdgfra− CD9+ cells as peribronchial fibro-
blasts (Fig. 7c). All GFP+ cells were also sorted for comparison.
We checked the expression of specific markers in sorted cells by
quantitative Real Time PCR (qPCR) analysis. As expected,
alveolar fibroblasts expressed Slc7a10, Npnt, and Ces1d (Fig. 7d,
Supplementary Fig. 7a). Adventitial fibroblasts expressed Pi16
(Fig. 7d). Il33 and Adh7 expressions were also enriched in
adventitial fibroblasts, suggesting that the Sca1+ gating collected
both clusters 4 and 6 (Supplementary Fig. 7a). Peribronchial
fibroblasts expressed Hhip and Aspn (Fig. 7d, Supplementary
Fig. 7a). Mcam+ cells highly expressed Pdgfrb and Acta2, which
are the markers for pericytes and smooth muscle cells (Fig. 7d,
Supplementary Fig. 7a). These results suggest that alveolar,
adventitial, peribronchial fibroblasts and Mcam+ smooth muscle
cells and pericytes can be purified based on Pdgfra, Sca1, and
CD9 expressions in Col-GFP mice.
A previous study showed that bulk GFP+ cells from uninjured
Col-GFP mice can colonize the lungs of bleomycin-treated, but
not untreated mice after intratracheal adoptive transfer28. We
used this transfer model to determine which of the subpopula-
tions we identified have this capacity. We purified alveolar
fibroblasts, adventitial fibroblasts, peribronchial fibroblasts, and
Mcam+ cells from untreated Col-GFP mice, and transferred
identical numbers of each subpopulation into bleomycin-treated
wild type mice (Fig. 7e). Four days post-transfer, we harvested
host lungs and counted GFP+ cells via flow cytometry. Among
the four populations, both adventitial fibroblasts and alveolar
fibroblasts showed engraftment potential, with adventitial fibro-
blasts colonizing modestly better than alveolar fibroblasts (Fig. 7f).
The engraftment potential of peribronchial fibroblasts was about
half that of alveolar fibroblasts (Fig. 7f). Mcam+ cells showed
minimal engraftment potential, confirming our previously
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published results with Mcam+ cells (Fig. 7f)28. Although
engraftment potential substantially varied among the populations,
qPCR analysis of sorted GFP+ cells from the host lungs showed
that engrafted cells from all the groups upregulated Cthrc1 and
Col1a1 compared to the untreated state (Fig. 7g, Supplementary
Fig. 7b), suggesting that these resting populations all have the
potential to upregulate Cthrc1 and Col1a1 in response to local
cues in the pro-fibrotic environment.
To explore molecular mechanisms that might be responsible
for the emergence of cluster 8 cells, we isolated alveolar fibroblasts
from untreated Col-GFP mice and treated the cells with growth
factors or cytokines including TGF-β, TNF-α, and EGF in vitro.
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We found that TGF-β stimulation induced several markers
of cluster 8 cells, including Col1a1, Cthrc1, Postn, and Tnc, while
TNF-α and EGF did not increase the expression of cluster 8
cell markers (Supplementary Fig. 7c). Spp1 and Fst was not
upregulated by TGF-β stimulation, suggesting that there are likely
to be other factors in the fibrotic microenvironment involved in
induction of the complete molecular phenotype of cluster 8 cells
in vivo (Supplementary Fig. 7c).
Purified Cthrc1+ fibroblasts show pathologic phenotype. Next,
we developed methods to purify Cthrc1+ pathologic fibroblasts
from bleomycin-treated mice. Time course analysis revealed that
the expressions of cluster 8 markers, such as Cthrc1, Fst, Spp1
and Col1a1, peaked around day 10 after bleomycin treatment in
Col-GFP+ cells (Supplementary Fig. 8a). In contrast, Pdgfra
expression was downregulated after bleomycin treatment (Sup-
plementary Fig. 8a). Flow cytometry of bleomycin-treated Col-
GFP mice showed the emergence of a Sca1− Pdgfra− Col-GFP-
high CD9-intermediate population not seen in untreated lungs
(Fig. 8a). We purified this population, which we refer to as cluster
8 here, and were also able to purify each of the collagen-producing
populations from the lungs of bleomycin-treated mice (Fig. 8a).
qPCR analysis of purified cells showed that Cthrc1 expression was
highly enriched in cluster 8 (Fig. 8b). Consistent with our scRNA-
seq data, Col1a1 expression was the highest in cluster 8 and Acta2
was enriched in Mcam+ cells (Fig. 8b). Of note, the markers for
alveolar, adventitial, and peribronchial fibroblasts were similarly
enriched by the same gating strategy used to purify the cells from
untreated lungs (Supplementary Fig. 8b).
In fibrotic lungs, the cells that produce excess quantities of
ECM are thought to arise in response to local injury and to
migrate into injured areas where they form aggregates called
fibroblastic foci that drive the fibrotic process29. We, therefore,
sought to determine whether Cthrc1+ fibroblasts have increased
the capacity to migrate in vitro and increased capacity to colonize
the lungs of bleomycin-treated mice. We performed gap
migration assays with cluster 8 cells, alveolar fibroblasts, and
adventitial fibroblasts, which were purified from bleomycin-
treated lungs on day 10 after treatment. Cluster 8 cells showed
substantially higher migration capacity than alveolar or adven-
titial fibroblasts (Fig. 8c, d). We also performed the intratracheal
transfer of cluster 8 cells, alveolar fibroblasts, or adventitial
fibroblasts purified from bleomycin-treated lungs. Two days after
the transfer, cluster 8 cells showed markedly higher engraftment
potential than either alveolar or adventitial fibroblasts (Fig. 8e).
Whole lung imaging of cleared host lungs also showed that
transferred cluster 8 cells formed larger clusters in the host lungs
than alveolar or adventitial fibroblasts (Fig. 8f). These results
suggest that, in addition to expressing higher levels of genes
encoding ECM proteins, Cthrc1+ fibroblasts have high migratory
capacity and are better able to colonize fibrosing lungs. Taken
together, our results suggest that Cthrc1+ fibroblasts are
pulmonary fibrosis-associated fibroblasts with a highly activated
phenotype.
Discussion
Our scRNA-seq results provide the first systematic atlas of the
molecular characteristics and anatomic locations of collagen-
producing cells in the adult lung. Our results confirm that smooth
muscle cells and pericytes express low levels of collagen in both
mice and humans, but that there are unique populations of cells
that express higher levels of collagen and reside in distinct ana-
tomic locations—the walls of conducting airways, surrounding
the bronchovascular bundles, and embedded within the gas-
exchanging alveolar region. We speculate that each population
plays unique functional roles in organizing and maintaining the
unique structures of each of these regions and in fibrotic
responses to regional insults.
By comparing scRNA-seq results between normal and fibrotic
lungs, we were also able to identify a unique population of cells
that expressed the highest levels of collagens and other known
components of the pathologic ECM, and were marked by high
levels of expression of Cthrc1 in both mice and human. These
cells were present within clusters of collagen-producing cells in
fibrotic regions, and displayed marked increase in their capacity
to migrate and to colonize the fibrosing lung after intratracheal
transfer, suggesting that they play important roles in driving
pulmonary fibrosis.
In the absence of available lineage tracing mouse lines to
definitively prove the origin of these cells, we used two different
computational tools—RNA velocity and pseudotime trajectory
analysis—which both suggested that these cells were most likely
to have differentiated from a population of alveolar fibroblasts.
Further support for this interpretation comes from our observa-
tions that levels of collagen expression progressively increased
from populations of alveolar fibroblasts seen mainly in normal
lungs, to populations of alveolar fibroblasts seen mainly in fibrotic
lungs, to the Cthrc1-expressing cells. In parallel, expression of
several markers shared by normal alveolar fibroblasts, including
Pdgfra, Tcf21, and Npnt decreased progressively over this same
continuum. Interestingly, both alveolar fibroblasts and adventitial
fibroblasts purified from normal lungs and transferred back into
the lungs of mice treated with intratracheal bleomycin were able
to colonize the lungs of bleomycin-treated mice and markedly
upregulated expression of Cthrc1 after transfer, suggesting sub-
stantial plasticity of these populations in response to a fibrotic
in vivo environment.
Myofibroblasts were first identified as contractile fibroblasts in
granulation tissue30. After cutaneous injury, progenitor cells
migrate into areas of injury and differentiate into myofibroblasts,
which generate force and contract wounds30. An increase in the
density of myofibroblasts in tissue is implicated in excessive
collagen deposition in some disease settings3,31. In addition,
adoptive transfer of purified fibroblasts in lung fibrosis showed
upregulation of α-SMA together with ECM genes in transferred
cells28,32. Our scRNA-seq data also show an increase in the
number of Acta2 expressing cells in Cthrc1+ fibroblasts compared
to their presumed progenitor, alveolar fibroblasts. However, the
highest level of α-SMA expression is observed in smooth muscle
cells and pericytes, which display low levels of collagen expres-
sion. These findings suggest that α-SMA is unsuitable as a specific
marker of pathologic ECM-producing cells in the lung.
We found that Cthrc1 is a marker for pathologic fibroblasts in
pulmonary fibrosis. Cthrc1 is expressed in injured tissue and
promotes cell migration33,34. Furthermore, invasive cancer cells
express CTHRC1 and high CTHRC1 expression in tumors is
associated with poor prognosis35,36. We found that Cthrc1+
fibroblasts from fibrotic lungs show high migration capacity and
high potential to engraft when transferred into injured lungs.
These findings are consistent with the previous suggestions that
an invasive phenotype of fibroblasts promotes pulmonary fibro-
sis37–40. In humans with pulmonary fibrosis we and others have
analyzed, CTHRC1+ fibroblasts emerged in pulmonary fibrosis
associated with IPF and scleroderma, suggesting that there might
be common mechanisms of fibrosis associated with CTHRC1+
fibroblasts in both diseases.
Lee et al. and Zepp et al. reported mesenchymal cells similar to
the peribronchial fibroblasts we describe here, that they reported
can differentiate into smooth muscle cells after airway injury5,15.
Although our scRNA-seq also showed some shared genetic sig-
nature between peribronchial fibroblasts and smooth muscle cells,
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15647-5 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1920 | https://doi.org/10.1038/s41467-020-15647-5 | www.nature.com/naturecommunications 11
lineage tracing experiments will need to be performed to deter-
mine whether these cells can serve as smooth muscle progenitors
in vivo. Our RNA velocity analysis did not show vectors towards
smooth muscle cells from peribronchial fibroblasts but this could
be because the rate of differentiation is too slow in normal or
bleomycin-treated lungs.
Adventitial fibroblasts have been known to play important
roles in tissue homeostasis and diseases41. Recent studies revealed
IL-33-expressing stromal cells support the development of group
2 innate lymphoid cells (ILC2) and form niches for ILC2 in
peripheral tissue11,42. In addition to these Il33+ adventitial
fibroblasts, we revealed another kind of adventitial fibroblast
characterized by Adh7 expression. The difference in physiological
or pathological roles of these two adventitial fibroblasts is an
intriguing question. Of note, we showed that adventitial fibro-
blasts have higher potential to engraft after transfer than alveolar
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fibroblasts. Taken together with a study showing Sca1+ stromal
cells have stem cell-like phenotypes and are multipotent43,
adventitial fibroblasts might also serve as progenitors for patho-
logic fibroblasts, perhaps in response to insults arising in prox-
imal regions of the lung or insults arising from the lung
vasculature.
In conclusion, we have built an atlas of collagen-producing
cells and identified several molecularly distinct cell types that
occupy unique anatomic locations. We have also identified a
novel population of cells unique to the fibrotic lung that produce
the highest levels of collagens and other ECM proteins, and show
the highest capacity to migrate and to colonize the fibrosing lung.
The development of tools to mark, ablate and modify gene
expression in each of these subtypes should provide important
insights into the lineage relationships, homeostatic and pathologic
roles of each of these cell types.
Methods
Mice and bleomycin treatment. Col-GFP mice were obtained from Dr. David
Brenner at University of California, San Diego, CA, and maintained on the C57BL/
6J background8. Shh-Cre (Stock No. 005622) and Rosa26-lox-stop-lox-tdTomato
(Stock No. 007914) mice were obtained from the Jackson Laboratory. Although the
Cre protein is fused with GFP in Shh-Cre mice, the expression of Shh is restricted
to epithelial cells and Col-GFP+ fibroblasts can be identified as GFP single-positive
cells while epithelial cells are all tdTomato+ in Col-GFP/Shh-Cre/Rosa26-lox-stop-
lox-tdTomato mice. We obtained C57BL/6J mice from the Jackson Laboratory
(stock no. 000664) as host mice for adoptive transfer experiments. Sex-matched
mice between the ages of 8 and 12 weeks old were used for the experiments. Female
mice were used for scRNA-seq. Both male and female mice were used in the other
experiments. For fibrosis induction, mice were treated with 3 U/kg bleomycin in 70
μl saline by oropharyngeal aspiration, except host mice for transfer experiments,
which were treated with 2 U/kg bleomycin. Mice were maintained in the UCSF
specific pathogen-free animal facility in accordance with guidelines established by
the Institutional Animal Care and Use Committee and Laboratory Animal
Resource Center. All animal experiments were in accordance with protocols
approved by the University of California, San Francisco Institutional Animal Care
and Use Committee.
Tissue dissociation. Mouse lungs were harvested after perfusion through the right
ventricle with 5 ml PBS. For human lungs, representative pieces were collected
from whole lungs and cut into 5 × 5 × 5 mm pieces. Approximately 1 g tissue was
randomly chosen from the pieces for digestion. After mincing with scissors, the
tissue was suspended in protease solution [0.25% Collagenase A (Millipore Sigma),
1 U/ml Dispase II (Millipore Sigma), 2000 U/ml Dnase I (Millipore Sigma) in
RPMI (Millipore Sigma) supplemented with 10 mM HEPES]. The suspension was
incubated at 37 °C for 60 min with trituration by micropipette every 20 min. Then
the cells were passed through 100 μm cell strainer (BD Biosciences), washed with
PBS, and suspended in PBS with 0.5% bovine serum albumin (BSA) (Fisher
BioReagents).
Flow cytometry. For scRNA-seq in mice, GFP+ and GFP− cells were sorted after
gating singlet, live (DAPI−), and Ter119−. For scRNA-seq in human, lineage
negative (CD31, CD45, EPCAM, CD235a)− or all lung cells (CD235a−) were
sorted after gating singlet and live cells (DAPI−). Donor cells for transfer experi-
ments were sorted following magnetic negative selection for CD31, CD45, Epcam,
and Ter119 by biotin-labeled antibodies and Dynabeads MyOne Streptavidin T1
(Thermo Fisher Scientific). The antibodies used were as follows: anti-CD9 (clone
MZ3, PE; BioLegend), anti-CD31 (clone 390, biotin; BioLegend), anti-CD45 (30F-
11, biotin; BioLegend), anti-Pdgfra (clone APA5, APC; BioLegend), anti-Mcam
(clone ME-9F1, PerCP/Cy5.5; BioLegend), anti-Epcam (clone G8.8, biotin; Bio-
Legend), anti-Sca1 (clone D7, PE/Cy7; BioLegend), streptavidin-APC/Cy7
(BioLegend), anti-hCD31 (clone WM59, PE/Cy7; BioLegend), anti-hCD45 (clone
HI30, APC; BioLegend), anti-hEPCAM (clone 9C4, FITC; BioLegend), anti-
hCD235a (clone HI264, APC/Cy7; BioLegend). Sorting was performed using FACS
Aria III (BD Biosciences). Flow cytometry data were analyzed using the FlowJo v10.
Human lung tissues. The studies described in this paper were conducted
according to the principles of the Declaration of Helsinki. Written informed
consent was obtained from all subjects, and the study was approved by the Uni-
versity of California, San Francisco Institutional Review Board. Fibrotic lung tissues
were obtained at the time of lung transplantation from patients with a diagnosis of
usual interstitial pneumonia or scleroderma. Normal lung tissues were obtained
from lungs rejected for transplantation by the Northern California Transplant
Donor Network.
scRNA-seq library preparation and sequencing. We collected lung cells from two
untreated and two bleomycin-treated (day 14) mice. After gating live cells and
Ter119− cells, GFP+ and GFP− cells were sorted and each sample were processed
separately. For human samples, lineage negative (CD31, CD45, CD235a, EPCAM)−
cells or all lung cells (CD235a−) were sorted. Approximately 1 × 105 cells were
sorted for each sample. The sorted cells were re-suspended in PBS with 0.05% BSA
and ~1 × 104 cells were loaded onto the Chromium controller (10x Genomics).
Chromium Single Cell 3’ v2 reagents were used for library preparation according to
the manufacturer’s protocol. For human samples, the libraries were stored at−20 °C
and 2–3 batches were pooled for sequencing. The libraries were sequenced on
Illumina HiSeq 4000 for mouse samples or NovaSeq 6000 for human samples.
Sequencing data processing for mouse data. Sequencing data were aligned to
mouse genome mm10 with Cell Ranger version 2.0 (10x Genomics). The data were
processed using the Seurat R package version 2.3.444. We excluded cells with fewer
than 250 detected genes or larger than 10% percent mitochondria genes. Samples
from untreated and bleomycin-treated lungs were aggregated with CCA subspace
alignment9. For Col1a1+ cell analysis, we aggregated GFP+ samples with CCA
subspace alignment, and clusters which expressed lineage markers for hemato-
poietic, endothelial, epithelial, and mesothelial cells were removed. Col1a1
expression was not consistently detectable among each of these removed clusters
except the small mesothelial cluster. Variable genes for dimensionality reduction
were selected using FindVariableGenes function of Seurat. We performed graph-
based clustering of the CCA reduced data using FindClusters function of Seurat
(resolution= 0.6, dims.use= 1:20). Visualization of the clusters on a 2D map was
performed with uniform manifold approximation and projection (UMAP)
(RunUMAP function of Seurat, dims.use= 1:20). Violin plots and UMAP plots
overlaid with gene expression level were generated using Seurat. Differentially
expressed genes of each cluster were identified using FindAllMarkers function of
Seurat.
RNA velocity and pseudotime trajectory analysis. We used the velocyto R
package v0.6 to estimate cell velocities from their spliced and unspliced mRNA
content18. We generated annotated spliced and unspliced reads from the 10x BAM
files via the dropEst pipeline, before calculating gene-relative velocity using kNN
pooling with k= 25, fitting gene offsets using spanning reads and a gamma fit on
the top/bottom 2% expression quantiles, and determining slope gamma with the
entire range of cellular expression. We visualized aggregate velocity fields (using
Gaussian smoothing on a regular grid) on the UMAP visualizations generated
previously in Seurat. To generate cellular pseudotemporal trajectories we used the
monocle R package v2.6.419. We ordered cells in an unsupervised manner (using
genes with mean expression >1 and empirical dispersion ≥2*dispersion model
estimate) and scaled the resulting pseudotime values between 0 and 1.
Sequencing data processing for human data. Sequencing data were aligned to
human genome GRCh38 with Cell Ranger version 2.0 or 3.0. The data were first
processed using the scran R package v1.1022. We excluded cells which were five
median absolute deviation distant from the median value of library size, number of
detected genes, or mitochondrial gene proportion. Variable genes were identified as
genes with the largest biological components across all the samples following
Fig. 8 Purified Cthrc1+ pathologic fibroblasts showed high migration and invasion capacity. a Gating strategy for purifying collagen-producing
populations from bleomycin-treated lungs. b qPCR analysis of purified cells from bleomycin-treated lungs (day 10). n= 4 mice. c Representative images
from gap migration assay with cells purified from bleomycin-treated lungs (day 10). Broken lines show initial cell-free zones. Col-GFP is shown in green.
Scale bars, 500 μm. d Quantification of migration assay. n= 4 mice. ***p < 0.001, two-way analysis of variance followed by the Tukey–Kramer post-test.
e The number of GFP+ cells from the host lungs, which received purified cells from bleomycin-treated lungs, were analyzed. n= 5 (adventitial) or 6 (cluster
8 and alveolar) mice. **p < 0.01, ***p < 0.001, one-way analysis of variance followed by the Tukey–Kramer post-test. f Whole lung imaging of host lungs.
Col-GFP (donor cells) is shown in green. Autofluorescence in RFP channel is shown in white to visualize host lung cells. Images were maximum projection
of z-stack images. Scale bars, 1 mm. b–f Data are representative from two experiments. b, d, e Data are means ± SEM. Source data are provided as a Source
Data file.
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decomposition of the variance in expression for each gene into biological and
technical components as described previously45. All samples were aggregated with
MNN-batch correction22. Aggregated data and MNN dimensionality reduction
were imported into Seurat. We performed graph-based clustering of the MNN
reduced data using FindClusters function of Seurat (resolution= 0.3, dims.use=
1:19). For lineage sample analysis, clusters which expressed epithelial and endo-
thelial markers were removed. Visualization of the clusters on a 2D map was
performed with UMAP (RunUMAP function of Seurat, dims.use= 1:19). Violin
plots and UMAP plots overlaid with gene expression level were generated using
Seurat. Differentially expressed genes of each cluster were identified using Fin-
dAllMarkers function of Seurat.
Sequencing data processing for the large data set. scRNA-seq data of IPF and
normal human lungs from the IPF Cell Atlas preprint23. Following unsupervised
clustering, stromal populations were identified on the basis of positive PDGFRB
expression, resulting in a total of 6607 cells: 1144 control cells from 26 subjects and
5463 cells from 32 IPF patients. Gene expression was normalized by first scaling
absolute UMI values to relative values of per 10,000 transcripts, followed by natural
log transformation with a pseudocount of 1 (i.e., log((TPM/100)+1). Amongst the
PDGFRB stromal cells, expressing was normalized with SCTransform 0.2.0 for the
top 10,000 defined variable genes to regress out signals associated with the fraction
of mitochondrial transcripts and the overall number of unique molecular identifiers
(UMIs), using seed:7. Variable features were selected with Seurat 3.1.0 using the
“mean variance plot” method, with a mean expression cutoff range between 0.15
and 4, and dispersion cutoff between 0.8 and 7. Amongst selected variable genes,
only genes normalized by SCTransform were selected for PCA analysis under the
default Seurat parameters. The top 6 dimensions were used for UMAP embedding
with a neighborhood size of 20, a minimum distance of 0.1, for 1000 epochs.
UMAPs featuring gene expression show the log((TPM/100)+1) values of expres-
sion per cell.
Sequencing data processing for publicly available data sets. Gene expression
matrices of Peyser et al. (GSE129605)20 and Morse et al. (GSE128033)25 were
processed using the Seurat R package version 2.3.4. Variable genes for dimen-
sionality reduction were selected using FindVariableGenes function of Seurat. The
samples were aggregated with RunMultiCCA function of Seurat. After performing
graph-based clustering of the CCA reduced data using FindClusters function of
Seurat, Col1a1-expressing clusters were picked up for further analysis. UMAP plots
overlaid with gene expression level were generated using Seurat.
PLISH. PLISH was performed as described previously with some modifications10.
Lungs were fixed with 4% paraformaldehyde (PFA) for 6 h on ice and dehydrated
with 30% sucrose overnight at 4 °C. Sixteen μm sections were made from optimal
cutting temperature compound (Sakura Finetek)-embedded frozen blocks. Target
retrieval was performed by treating the sections with 10 mM citrate buffer con-
taining 0.05% lithium dodecyl sulfate at 100 °C for 5 min and with 0.25 mg/ml
pepsin in 0.1 M HCl at 37 °C for 5 min. The sections were incubated with H-probes
in H-probe buffer at 37 °C for 2 h, followed by incubation with phosphorylated
common bridge and circle oligonucleotides at 37 °C for 1 h. After incubation in
ligation buffer at 37 °C for 2 h, the sections were incubated in RCA buffer at 37 °C
overnight. Then the sections were incubated in labeling buffer containing Cy3 and
Cy5-labeled oligonucleotide at 37 °C for 1 h. After washing with PBS with 0.05%
tween 20, the sections were stained with chicken anti-GFP antibody (ab13970,
Abcam) at room temperature for 1 h, followed by incubation with donkey anti-
chicken alexa 488 secondary antibody (Jackson Immuno Research) and DAPI
(Thermo Fisher) at room temperature for 1 h. The sections were mounted with
ProLong Glass antifade Mountant (ThermoFisher). Images were taken using Zeiss
780 confocal microscope. Oligonucleotide sequences used are listed in Supple-
mentary Table 1.
Immunohistochemistry (IHC) and ISH staining for human samples. Chromo-
genic IHC and in situ hybridization (ISH) staining for human samples were per-
formed on an automated Bond RX immunostainer (Leica) as described below.
4 μm microtome sections of formalin-fixed, paraffin-embedded (FFPE) healthy and
diseased IPF lung were collected on slides for IHC and ISH staining. For IHC
staining, heat-induced epitope retrieval was performed by treating the sections with
citrate buffer at 90 °C for 30 min. Sections were incubated with rabbit anti-
CTHRC1 antibody (ab85739, Abcam) or anti-α-SMA antibody (ab5694, Abcam) at
ambient temperature for 30 min, followed by Bond Polymer Refine Red Detection
(DS9390, Leica). ISH staining was performed following Advanced Cell Diagnostic’s
(ACD) standard Bond RX automated ISH protocol using RNAscope® 2.5 LS
Reagent Kit-RED (Advanced Cell Diagnostics) and Bond Polymer Refine Red
Detection (DS9390, Leica). RNAscope® LS 2.5 Probes against human CTHRC1
(413338, ACD) were ordered from ACD with hybridization optimized for human
skin (EDTA for 15 min at 88 °C). Stained slides were digitized for image analysis
using a Perkin Elmer P250 whole slide digital pathology slide scanner with
20×(IHC) or 40×(ISH) objective and extended focus scanning parameters.
Imaging cleared lung tissues. Untreated lungs of Col-GFP mice were fixed with
4% PFA overnight at 4 °C and then inflated with low-melting point agarose. 100
μm sections were made using a vibratome VT1000S (Leica). The sections were
cleared using a CUBIC method as described previously46. After delipidation with
Reagent-1A (10 wt% triton, 5 wt% NNNN-tetrakis (2-HP) ethylenediamine,
10 wt% urea, 25 mM NaCl), the sections were stained with anti-α-SMA-alexa 647
(R&D), or anti-collagen 4 (LSL) followed by donkey anti-rabbit IgG-alexa 647
(Thermo Fisher). The sections were then treated with refractive index-matching
reagent (Reagent-2; 25 wt% urea, 50 wt% sucrose, 10 wt% triethanolamine) and
imaged using W1 spinning disk confocal microscope (Nikon). Images were
processed using Image J version 1.52i. 3D-reconstruction of z-stack images was
performed using Icy version 2.0. For whole lung imaging after transfer, 4% PFA-
fixed lungs were cleared with Reagent-1A and treated with Reagent-2,
followed by imaging for GFP signal using Nikon AZ100 microscope configured
as light sheet microscopy. Autofluorescence signal in RFP channel was used to
visualize the lung structure. Maximum projection images were generated using
Image J.
Quantitative real-time PCR analysis. Approximately 2000 cells were directly
sorted into TRIzol reagent (Thermo Fisher), and RNA was isolated according to
the manufacturer’s protocol. The RNA was reverse-transcribed using a Super Script
IV VILO Master Mix with ezDNase Enzyme kit (Thermo Fisher). Quantitative
Real-Time PCR was performed using 2x SYBR Green qPCR Master Mix (Bimake)
with an ABI 7900HT (Applied Biosystems). Primer sequences are listed in Sup-
plementary Table 2.
Primary alveolar fibroblast in vitro stimulation. Alveolar fibroblasts were sorted
from untreated Col-GFP mice. 1 × 105 cells were seeded into 48 well plates and
cultured in DMEM (Corning) with 2% fetal bovine serum (FBS) (Gibco) and 1%
penicillin–streptomycin (Gibco) for 24 h. Then medium was changed to serum-free
DMEM with 1% penicillin/streptomycin for 24 h. After the serum starvation,
medium was changed to serum-free DMEM with 1% penicillin/streptomycin,
containing 1 ng/ml TGF-b (R&D), 10 ng/ml TNF-a (R&D), or 10 ng/ml EGF
(Thermo Fisher). After 24 h stimulation, cells were lysed by directly adding 500 μl
Trizol into the wells. Cell culture was performed under standard conditions (37 °C,
5% CO2).
Intratracheal adoptive transfer. Donor cells were collected from untreated or
bleomycin-treated (day 10) Col-GFP mice. Fibroblast subpopulations were sorted
into PBS with 0.5% BSA. After resuspending the sorted cells in smaller volume of
PBS with 0.5% BSA, live cell number was counted and cell concentrations were
adjusted so that each sample had identical cell concentration. 70 μl of cell sus-
pension was instilled into bleomycin-treated wild type mice (day 7) by orophar-
yngeal aspiration. 1–3 × 105 cells were transferred per mouse.
Migration assay. Fibroblast subpopulations were sorted into PBS with 0.5% BSA.
1 × 105 cells were resuspended in 100 μl DMEM (Millipore Sigma) with 2% fetal
bovine serum (FBS) and dispensed into each well of Oris cell migration assay kit
(fibronectin-coated) (Platypus Technologies). After 24 h incubation in a CO2
incubator, the stoppers were removed and the wells were refilled with 100 μl
DMEM with 2% FBS after washing with 100 μl PBS. The plate was incubated in a
CO2 incubator and GFP+ cells were imaged after 24 and 48 hr using Zeiss spinning
disk confocal microscopy. GFP+ area in the central circle were quantified using
Image J.
Data analysis. scRNA-seq data analysis was performed in R version 3.5.1. Sta-
tistical tests were performed in GraphPad Prism version 8.1.2.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The scRNA-seq data generated in this study are deposited in Gene Expression Omnibus
(GEO) (GSE132771). The mesenchymal subset of large scRNA-seq data set of 29 normal
and 32 IPF lungs23 is deposited in GEO (GSE147066). An interactive online tool for the
data set is available at www.IPFCellAtlas.com. The source data underlying Figs. 7d, f, g,
8b, and e, and Supplementary Figs. 7a–c, 8a and b are provided as a Source Data file.
Code availability
The codes used in scRNA-seq analysis are available from the authors upon reasonable
requests.
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